This Article Figures Only Full Text Full Text (PDF) View Related Journal Scan on Cardiosource Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Prasad, A. Articles by Stone, G. W. Search for Related Content PubMed PubMed Citation Articles by Prasad, A. Articles by Stone, G. W. Related Collections Related Articles

CLINICAL RESEARCH: ACUTE CORONARY SYNDROME

Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

Abhiram Prasad, MD^_*, Bernard J. Gersh, MB, ChB, DPhil, MD^_*, Michel E. Bertrand, MD, A. Michael Lincoff, MD, Jeffrey W. Moses, MD, E. Magnus Ohman, MD^||, Harvey D. White, MD^¶, Stuart J. Pocock, PhD^#, Brent T. McLaurin, MD^_**, David A. Cox, MD, Alexandra J. Lansky, MD, Roxana Mehran, MD and Gregg W. Stone, MD^,_*

^_* Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Hôpital Cardiologique, Lille, France
Cleveland Clinic, Cleveland, Ohio
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
^|| Duke University Medical Center, Durham, North Carolina
^¶ Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
^# London School of Hygiene and Tropical Medicine, London, United Kingdom
^_** Anderson Heart, Anderson, South Carolina
Mid Carolina Cardiology, Charlotte, North Carolina

Manuscript received December 30, 2008; revised manuscript received February 19, 2009, accepted March 24, 2009.

^_* Reprint requests and correspondence: Dr. Gregg W. Stone, The Cardiovascular Research Foundation, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, New York 10032 (Email: gs2184{at}columbia.edu).

Objectives: The aim of this study was to evaluate the relative impact of spontaneously occurring and periprocedural myocardial infarction (MI) on survival after percutaneous coronary intervention (PCI).

Background: The clinical significance of periprocedural MI after PCI remains uncertain.

Methods: Outcomes during a 1-year follow-up were evaluated among 7,773 patients enrolled in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial with a non–ST-segment elevation acute coronary syndrome in whom PCI was performed.

Results: Periprocedural MI developed in 466 patients (6.0%), and spontaneous MI unrelated to PCI subsequently developed in 200 patients (2.6%). Patients developing spontaneous and periprocedural MI compared with those patients without MI had significantly greater unadjusted rates of mortality at 30 days (5.0% vs. 3.2% vs. 0.8%, respectively, p < 0.0001) and at 1 year (16.0% vs. 6.0% vs. 2.6%, respectively, p < 0.0001). In a time-updated multivariable analysis, after adjusting for differences in baseline and procedural characteristics between the groups, we found that spontaneous MI was a powerful independent predictor of subsequent mortality (hazard ratio: 7.49, 95% confidence interval: 4.95 to 11.33, p < 0.0001), whereas periprocedural MI was not a significant predictor of mortality (hazard ratio: 1.30, 95% confidence interval: 0.85 to 1.98, p = 0.22).

Conclusions: Among patients with acute coronary syndrome undergoing PCI, the spontaneous development of an MI unrelated to PCI is a powerful predictor of subsequent mortality. In contrast, periprocedural MI is a marker of baseline risk, atherosclerosis burden, and procedural complexity but in most cases does not have independent prognostic significance. (Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes [ACS]; NCT00093158)

Key Words: angioplasty • myocardial infarction • prognosis

Abbreviations and Acronyms   ACS = acute coronary syndrome   CK-MB = creatine phosphokinase MB fraction   MI = myocardial infarction   PCI = percutaneous coronary intervention   ULN = upper limit of normal

Related Articles

Periprocedural Myocardial Injury: Not a Benign Entity

Chris C.S. Lim, William J. Van Gaal, and Adrian P. Banning
J. Am. Coll. Cardiol. 2010 55: 503. [Full Text] [PDF]

This article has been cited by other articles:

				P. Damman, L. Wallentin, K. A. A. Fox, F. Windhausen, A. Hirsch, T. Clayton, S. J. Pocock, B. Lagerqvist, J. G. P. Tijssen, and R. J. de Winter Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR) Circulation, January 31, 2012; 125(4): 568 - 576. [Abstract] [Full Text] [PDF]

				A. S. Jaffe, F. S. Apple, B. Lindahl, C. Mueller, and H. A. Katus Why all the struggle about CK-MB and PCI? Eur. Heart J., January 11, 2012; (2012) ehr502v1. [Full Text] [PDF]

				G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J. Am. Coll. Cardiol., December 6, 2011; 58(24): e44 - e122. [Full Text] [PDF]

				Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation, December 6, 2011; 124(23): e574 - e651. [Full Text] [PDF]

				J. A. Goldstein, B. Maini, S. R. Dixon, E. S. Brilakis, C. L. Grines, D. G. Rizik, E. R. Powers, D. H. Steinberg, K. A. Shunk, G. Weisz, et al. Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction Circ Cardiovasc Interv, October 1, 2011; 4(5): 429 - 437. [Abstract] [Full Text] [PDF]

				C. C. S. Lim, W. J. van Gaal, L. Testa, F. Cuculi, J. R. Arnold, T. Karamitsos, J. M. Francis, S. E. Petersen, J. E. Digby, S. Westaby, et al. With the "Universal Definition," Measurement of Creatine Kinase-Myocardial Band Rather Than Troponin Allows More Accurate Diagnosis of Periprocedural Necrosis and Infarction After Coronary Intervention J. Am. Coll. Cardiol., February 8, 2011; 57(6): 653 - 661. [Abstract] [Full Text] [PDF]

				A. J. Lansky and G. W. Stone Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention Circ Cardiovasc Interv, December 1, 2010; 3(6): 602 - 610. [Full Text] [PDF]

				C. Cavallini, P. Verdecchia, S. Savonitto, G. Arraiz, R. Violini, Z. Olivari, P. Rubartelli, S. De Servi, M. Plebani, G. Steffenino, et al. Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention Circ Cardiovasc Interv, October 1, 2010; 3(5): 431 - 435. [Abstract] [Full Text] [PDF]

				P. Schoenhagen and H. D. White Magnetic Resonance Imaging and Troponin Elevation Following Percutaneous Coronary Intervention: New Insights Into Myocyte Necrosis and Scar Formation J. Am. Coll. Cardiol. Intv., September 1, 2010; 3(9): 959 - 962. [Full Text] [PDF]

				G. Di Sciascio, G. Patti, V. Pasceri, L. Gatto, G. Colonna, A. Montinaro, and on behalf of the ARMYDA-5 PRELOAD Investigators Effectiveness of In-Laboratory High-Dose Clopidogrel Loading Versus Routine Pre-Load in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Randomized Trial J. Am. Coll. Cardiol., August 10, 2010; 56(7): 550 - 557. [Abstract] [Full Text] [PDF]

				G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro, and on behalf of the ARMYDA-4 RELOAD Investigators Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial Eur. Heart J., June 1, 2010; 31(11): 1337 - 1343. [Abstract] [Full Text] [PDF]

				K. A. A. Fox, T. C. Clayton, P. Damman, S. J. Pocock, R. J. de Winter, J. G. P. Tijssen, B. Lagerqvist, L. Wallentin, and for the FIR Collaboration Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Meta-Analysis of Individual Patient Data J. Am. Coll. Cardiol., June 1, 2010; 55(22): 2435 - 2445. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., May 18, 2010; 55(20): 2272 - 2286. [Full Text] [PDF]

				F. Cuculi, C. C. S. Lim, and A. P. Banning Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented? Heart, May 1, 2010; 96(10): 736 - 740. [Abstract] [Full Text] [PDF]

				J. A. Bittl and D. J. Maron Having It Both Ways J. Am. Coll. Cardiol., March 2, 2010; 55(9): 865 - 866. [Full Text] [PDF]

				C. C.S. Lim, W. J. Van Gaal, and A. P. Banning Periprocedural Myocardial Injury: Not a Benign Entity J. Am. Coll. Cardiol., February 2, 2010; 55(5): 503 - 503. [Full Text] [PDF]

				G. W. Stone, A. Prasad, and B. J.. Gersh Reply J. Am. Coll. Cardiol., February 2, 2010; 55(5): 503 - 504. [Full Text] [PDF]

				A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al. Highlights of the Year in JACC 2009 J. Am. Coll. Cardiol., January 26, 2010; 55(4): 380 - 407. [Full Text] [PDF]

				S. Tsimikas High-Dose Statins Prior to Percutaneous Coronary Intervention: A Paradigm Shift to Influence Clinical Outcomes in the Cardiac Catheterization Laboratory J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2164 - 2166. [Full Text] [PDF]